🟢 96/100

This product looks safe

  • Byroviron: 1000mg is 22.2× the Tolerable Upper Intake Level (45mg)
  • 33% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Byroviron: 1000mg is 22.2× the Tolerable Upper Intake Level (45mg)

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

450 mg
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 450mg
10 mg
📊 7.7× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 10mg UL 100mg
1000 mg
⚠️ Exceeds Tolerable Upper Intake Level by 22.2× (UL: 45 mg) 📚 499 studies (Tier A: 17, B: 273)
RDA 8mg This product: 1000mg UL 45mg
Anacyclus pyrethrum
375 mg
Epicatechin
150 mg
📊 Market median: 50.0mg (57 products) 📚 17 studies — no high-quality reviews
This product: 50mg UL 50mg
5-Alpha-Hydroxy-Laxogenin
50 mg
Androsta-3,5-Diene-7,17-Dione
50 mg
BioPerine
5 mg

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide

Label Claims — Verification

Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult Male (18-50 Years)

Product Information

🧪 Formulation Notes

Test booster Strength Growth

Male heath

Product Details

DSLD Entry Date 2020-05-22
Product Type Other Combinations
Form Capsule
Brand FS
DSLD ID 219375
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →